• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 EWGSOP1 和 EWGSOP2 标准以及区域性阈值,并在特定老年门诊进行不同调整的肌少症横断面研究。

A cross-sectional study on sarcopenia using EWGSOP1 and EWGSOP2 criteria with regional thresholds and different adjustments in a specific geriatric outpatient clinic.

机构信息

Section of Geriatrics, Department of Internal Medicine, School of Medicine, Ege University, Bornova, Izmir, 35100, Turkey.

出版信息

Eur Geriatr Med. 2020 Apr;11(2):239-246. doi: 10.1007/s41999-019-00256-3. Epub 2019 Nov 6.

DOI:10.1007/s41999-019-00256-3
PMID:32297186
Abstract

PURPOSE

The aim of this study was to determine the prevalence of sarcopenia according to different methods in older outpatients using regional threshold values of muscle mass and muscle strength.

METHODS

We used data from our university hospital's geriatric outpatient clinic specific to endocrinological problems, retrospectively. Sarcopenia was defined according to European Working Group on Sarcopenia in Older People (EWGSOP)1 and EWGSOP2 criteria using regional threshold values of skeletal muscle mass (SMM) with the use of different adjustments, and also according to EWGSOP2 with regional threshold values of grip strength.

RESULTS

Among 248 study participants, 53.6% were obese. There was no sarcopenic patient with the height square adjusted regional SMM thresholds for EWGSOP1 and EWGSOP2. Sarcopenia prevalence was 11.7% with EWGSOP2, and 41.1% by the use of regional grip strength thresholds for EWGSOP2 with body mass index adjustments for SMM. The comparison of EWGSOP1 versus EWGSOP2 was not possible due to lack of sarcopenic patients with height adjustment.

CONCLUSIONS

The prevalence of sarcopenia varied significantly with the application of different adjustment methods for SMM, and the use of regional grip strength thresholds in the specific patient group with normal to overweight and obese individuals. The use of regional thresholds of grip strength increased the prevalence of EWGSOP2-defined sarcopenia. The impact of the adjustment methods, the characteristics of the study population, and the regional thresholds should be taken into consideration while evaluating the results of sarcopenia studies.

摘要

目的

本研究旨在使用肌肉质量和肌肉力量的区域阈值来确定根据不同方法在老年门诊患者中肌少症的患病率。

方法

我们使用了来自我们大学医院内分泌专科门诊的回顾性数据。根据欧洲老年人肌少症工作组(EWGSOP)1 和 EWGSOP2 标准,使用不同调整的骨骼肌质量(SMM)区域阈值,以及根据 EWGSOP2 使用区域握力阈值来定义肌少症。

结果

在 248 名研究参与者中,53.6%为肥胖。根据 EWGSOP1 和 EWGSOP2 的身高平方调整的区域 SMM 阈值,没有肌少症患者。使用 EWGSOP2 时肌少症的患病率为 11.7%,使用 BMI 调整 SMM 的区域握力阈值时为 41.1%。由于缺乏身高调整的肌少症患者,因此无法比较 EWGSOP1 与 EWGSOP2。

结论

SMM 不同调整方法的应用使肌少症的患病率差异显著,并且在超重和肥胖个体的特定患者群体中使用区域握力阈值。使用区域握力阈值增加了 EWGSOP2 定义的肌少症的患病率。在评估肌少症研究结果时,应考虑调整方法、研究人群的特点和区域阈值的影响。

相似文献

1
A cross-sectional study on sarcopenia using EWGSOP1 and EWGSOP2 criteria with regional thresholds and different adjustments in a specific geriatric outpatient clinic.使用 EWGSOP1 和 EWGSOP2 标准以及区域性阈值,并在特定老年门诊进行不同调整的肌少症横断面研究。
Eur Geriatr Med. 2020 Apr;11(2):239-246. doi: 10.1007/s41999-019-00256-3. Epub 2019 Nov 6.
2
Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients.应用新的 EWGSOP2 指南而非旧的 EWGSOP 指南对老年患者进行肌肉减少症病例发现的后果。
Age Ageing. 2019 Sep 1;48(5):719-724. doi: 10.1093/ageing/afz035.
3
Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review.根据 EWGSOP1 和 EWGSOP2 诊断老年人肌少症的流行率及其与不良健康结局的相关性:系统评价。
Aging Clin Exp Res. 2022 Mar;34(3):505-514. doi: 10.1007/s40520-021-01951-7. Epub 2021 Aug 16.
4
Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents.修订的 EWGSOP 标准与其他四种肌少症诊断标准在中国社区居住的老年居民中的比较。
Exp Gerontol. 2020 Feb;130:110798. doi: 10.1016/j.exger.2019.110798. Epub 2019 Dec 6.
5
Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults.比较欧洲老年人肌肉减少症工作组(EWGSOP)2010 年和 2019 年的肌肉减少症诊断标准在两个瑞典老年人队列中的应用。
BMC Geriatr. 2021 Oct 26;21(1):600. doi: 10.1186/s12877-021-02533-y.
6
EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: Analysis from a large-scale prospective study.比较EWGSOP2与EWGSOP1在胃癌根治术后肌少症预测预后方面的应用:一项大规模前瞻性研究的分析
Clin Nutr. 2020 Jul;39(7):2301-2310. doi: 10.1016/j.clnu.2019.10.024. Epub 2019 Nov 5.
7
Self Reported Dysphagia is not Associated with Sarcopenia Defined by the Revised EWGSOP2 Criteria and Regional Thresholds at the Hospital Among Ambulatory Older Patients.自我报告的吞咽困难与根据修订的EWGSOP2标准和医院门诊老年患者区域阈值定义的肌肉减少症无关。
Mater Sociomed. 2019 Dec;31(4):253-257. doi: 10.5455/msm.2019.31.253-257.
8
Low Agreement Between Initial and Revised European Consensus on Definition and Diagnosis of Sarcopenia Applied to People Living With HIV.初始和修订的欧洲共识对肌少症的定义和诊断标准在 HIV 感染者中的应用具有低一致性。
J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):e106-e113. doi: 10.1097/QAI.0000000000002576.
9
Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus.2010 年和 2018 年欧洲共识(EWGSOP)对 2 型糖尿病老年患者的肌少症患病率及相关因素的差异。
Exp Gerontol. 2020 Apr;132:110835. doi: 10.1016/j.exger.2020.110835. Epub 2020 Jan 15.
10
New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes?新老肌少症分类指南比较:对患病率和健康结局有何影响?
Age Ageing. 2020 Feb 27;49(2):300-304. doi: 10.1093/ageing/afz126.

引用本文的文献

1
The association of muscle weakness with functional disability in older patients with Diabetes mellitus: Measured by three different grip strength thresholds.老年糖尿病患者肌肉无力与功能残疾的关联:通过三种不同握力阈值进行测量
PLoS One. 2025 Jan 30;20(1):e0317250. doi: 10.1371/journal.pone.0317250. eCollection 2025.
2
The Relationship between Chronic Musculoskeletal Pain and Sarcopenia Risk in Community-Dwelling Older Adults: A Cross-Sectional Study.社区居住老年人慢性肌肉骨骼疼痛与肌肉减少症风险的关系:一项横断面研究。
Ann Geriatr Med Res. 2023 Sep;27(3):250-257. doi: 10.4235/agmr.23.0081. Epub 2023 Aug 28.
3
Comparison of Grip Strength Measurements by Widely Used Three Dynamometers in Outpatients Aged 60 Years and Over.
60岁及以上门诊患者中广泛使用的三种握力计测量握力的比较。
J Clin Med. 2023 Jun 25;12(13):4260. doi: 10.3390/jcm12134260.
4
Accuracy of handgrip and respiratory muscle strength in identifying sarcopenia in older, community-dwelling, Brazilian women.手握力和呼吸肌力量在识别老年、社区居住的巴西女性肌少症中的准确性。
Sci Rep. 2023 Jan 27;13(1):1553. doi: 10.1038/s41598-023-28549-5.
5
Comparison of Habitual and Maximal Gait Speed and their Impact on Sarcopenia Quantification in German Nursing Home Residents.德国养老院居民习惯性和最大步速的比较及其对肌肉减少症量化的影响。
J Frailty Sarcopenia Falls. 2022 Dec 1;7(4):199-206. doi: 10.22540/JFSF-07-199. eCollection 2022 Dec.
6
Sarcopenia and mortality risk in community-dwelling Brazilian older adults.肌少症与巴西社区居住老年人的死亡风险。
Sci Rep. 2022 Oct 20;12(1):17531. doi: 10.1038/s41598-022-22153-9.
7
Screening for frailty and sarcopenia in community-dwelling older adults: a cross-sectional study from the Eastern Black Sea region of Turkey.社区居住的老年人衰弱和肌少症的筛查:来自土耳其黑海东部地区的横断面研究。
Aging Clin Exp Res. 2022 Sep;34(9):2047-2056. doi: 10.1007/s40520-022-02164-2. Epub 2022 Jun 15.
8
Impact of Different Operational Definitions of Sarcopenia on Prevalence in a Population-Based Sample: The Salus in Apulia Study.不同肌少症操作性定义对人群患病率的影响:普利亚地区 Salus 研究。
Int J Environ Res Public Health. 2021 Dec 9;18(24):12979. doi: 10.3390/ijerph182412979.
9
Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults.比较欧洲老年人肌肉减少症工作组(EWGSOP)2010 年和 2019 年的肌肉减少症诊断标准在两个瑞典老年人队列中的应用。
BMC Geriatr. 2021 Oct 26;21(1):600. doi: 10.1186/s12877-021-02533-y.
10
Is there a relationship between ACTN3 R577X gene polymorphism and sarcopenia?ACTN3 R577X 基因多态性与肌肉减少症之间是否存在关系?
Aging Clin Exp Res. 2022 Apr;34(4):757-765. doi: 10.1007/s40520-021-01996-8. Epub 2021 Oct 22.